NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: CHU de Quebec-Universite Laval
Conditions: Urinary Retention, Colorectal Surgery, Rectal Resection, Post-operative Urinary Retention, Tamsulosin
Interventions: pr Sandoz Tamsulosin, Glucose
Countries: Canada
The study will be a phase III double-blind randomized clinical trial. Participants will be recruited from the Department of General Surgery of the CHU de Québec - Saint-François-d'Assise and Hôtel-Dieu de Québec. The primary outcomes are the incidence of postoperative urinary retention in men undergoing rectal resection and the efficacy of prophylactic tamsulosin to prevent this type of complication.The secondary outcomes are the length of stay between experimental and placebo groups, the number of urinary catheterizations, the number of urine catheter reinsertions and total duration of urinary catheter being in-situ.
Sex: MALE
Age: 18 Years to —
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Inclusion Criteria: * Male patients * 18 years and older * Scheduled for rectal resection during the study period. Exclusion Criteria: * Patients undergoing revisional surgery * Patients taking alpha-blocker medication, * Patients who have an indwelling urinary catheter, * Patients who have undergone urinary tract surgery, * Patients who will have an intraoperative trauma of the urinary tract, * Patients who will keep their urinary catheter for more than 24 hours after surgery, * Patients who have an intolerance to alpha-blocking drugs or who take one of the following drugs (potential interaction): anti-retroviral, antifungal, clarithromycin, erythromycin, paroxetine, terbinafine, cimetidine, coumadin or phosphodiesterase inhibitors. * Patients who will have an epidural anesthesia
- Québec, Quebec, Canada